Bit Capital Gmb H Silence Therapeutics PLC Transaction History

Bit Capital Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$6.33 - $19.65 $585,075 - $1.82 Million	-92,429 Closed	0 $0
Q3 2024 Feb 12, 2025	SELL	$15.53 - $21.74 $136,757 - $191,442	-8,806 Reduced 8.7%	92,429 $1.68 Billion
Q2 2024 Feb 12, 2025	BUY	$18.31 - $23.91 $224,022 - $292,538	12,235 Added 13.75%	101,235 $1.92 Billion
Q1 2024 Feb 12, 2025	BUY	$17.39 - $26.25 $1.55 Million - $2.34 Million	89,000 New	89,000 $1.92 Billion

28.1M

300

Ticker SLN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,888,400
Market Cap $161M
Description
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.